Photodynamic therapy for therapy-resistant cancers will greatly benefit from targeted delivery of tumor photosensitizing agents. In this study, a strategy for the site-specific conjugation of single domain antibodies onto liposomes containing the photosensitizer zinc phthalocyanine was developed and tested
Zinc phthalocyanine (ZnPc) is a promising photosensitizer for photodynamic therapy, but faces some c...
Coupling of photosensitizers to tumor-selective monoclonal antibodies (MAbs) is an attractive option...
Photodynamic therapy (PDT) is a promising non-invasive strategy in the fight against that which circ...
Photodynamic therapy for therapy-resistant cancers will greatly benefit from targeted delivery of tu...
Photodynamic therapy (PDT) is a promising approach for the treatment of superficially localized tumo...
Photodynamic therapy (PDT) is a promising approach for the treatment of superficially localized tumo...
Contemporary photodynamic therapy (PDT) for the last-line treatment of refractory cancers such as na...
Photodynamic therapy (PDT) is a promising cancer treatment which involves a photosensitizer (PS), li...
Background: Efficacy of photodynamic therapy can be enhanced by improving uptake, localization, and ...
Photosensitizer immunoconjugates (PICs) offer improved photosensitizer delivery specificity and coul...
Targeting photosensitizers to cancer cells by conjugating them with specific antibodies, able to rec...
Photodynamic therapy (PDT) induces cell death through light activation of a photosensitizer (PS). Ta...
The use of monoclonal antibodies (MAbs) directed against tumor-associated antigens for targeting of ...
Photodynamic therapy (PDT) is an approach that kills (cancer) cells by the local production of toxic...
Phototherapy, the use of light to selectively ablate cancerous tissue, is a compelling prospect. Pho...
Zinc phthalocyanine (ZnPc) is a promising photosensitizer for photodynamic therapy, but faces some c...
Coupling of photosensitizers to tumor-selective monoclonal antibodies (MAbs) is an attractive option...
Photodynamic therapy (PDT) is a promising non-invasive strategy in the fight against that which circ...
Photodynamic therapy for therapy-resistant cancers will greatly benefit from targeted delivery of tu...
Photodynamic therapy (PDT) is a promising approach for the treatment of superficially localized tumo...
Photodynamic therapy (PDT) is a promising approach for the treatment of superficially localized tumo...
Contemporary photodynamic therapy (PDT) for the last-line treatment of refractory cancers such as na...
Photodynamic therapy (PDT) is a promising cancer treatment which involves a photosensitizer (PS), li...
Background: Efficacy of photodynamic therapy can be enhanced by improving uptake, localization, and ...
Photosensitizer immunoconjugates (PICs) offer improved photosensitizer delivery specificity and coul...
Targeting photosensitizers to cancer cells by conjugating them with specific antibodies, able to rec...
Photodynamic therapy (PDT) induces cell death through light activation of a photosensitizer (PS). Ta...
The use of monoclonal antibodies (MAbs) directed against tumor-associated antigens for targeting of ...
Photodynamic therapy (PDT) is an approach that kills (cancer) cells by the local production of toxic...
Phototherapy, the use of light to selectively ablate cancerous tissue, is a compelling prospect. Pho...
Zinc phthalocyanine (ZnPc) is a promising photosensitizer for photodynamic therapy, but faces some c...
Coupling of photosensitizers to tumor-selective monoclonal antibodies (MAbs) is an attractive option...
Photodynamic therapy (PDT) is a promising non-invasive strategy in the fight against that which circ...